abrdn Life Sciences Investors (HQL) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 0 252 sessions, September 24, 2025 to September 24, 2026
- Largest daily move
- +4.4% close of August 19, 2026
- 1-year change
- +34% closing prices, September 24, 2025 to September 24, 2026
- 5-year change
- -9.8% closing prices, September 24, 2021 to September 24, 2026
Company Description
abrdn Life Sciences Investors (NYSE: HQL) is classified in the asset management industry within the Financial Services sector and carries a market capitalization of $585.1M.
HQL has gained 34.0% over the past year. The last closing price was $19.27.
This page collects what Stock Titan holds for HQL, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
abrdn Life Sciences Investors (HQL) closed at $19.27 on September 24, 2026. Over the past 12 months, the price has gained 34.0%.
HQL Metrics & Rankings
Price returns through September 24, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
abrdn Life Sciences Investors has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include buybacks. View all HQL news →
SEC Filings
abrdn Life Sciences Investors has filed 10 recent SEC filings, including 5 Form SCHEDULE 13D/A, 2 Form 3, 2 Form 4, 1 Form SCHEDULE 13G/A. The most recent filing was submitted on July 20, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all HQL SEC filings →
Insider Radar
Insider buying activity at abrdn Life Sciences Investors over the past 90 days may reflect management confidence in the company's direction. Institutional investors and analysts often monitor insider purchases as a potential bullish indicator for the stock.
Financial Highlights
Upcoming Events
Short Interest History
Short interest in abrdn Life Sciences Investors (HQL) currently stands at 100.2 thousand shares, up 70.9% from the previous reporting period, representing 0.3% of the shares outstanding. Since September 2025, short interest has increased by 160.3%.
Days to Cover History
Days to cover for abrdn Life Sciences Investors (HQL) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
HQL Company Profile & Sector Positioning
abrdn Life Sciences Investors (HQL) operates in the Asset Management industry within the broader Financial Services sector and is listed on the NYSE. Among dividend-paying stocks, HQL ranks #120 by dividend yield.
Investors comparing HQL often look at related companies in the same sector, including Blackrock Health Sciences Trust (BME), BlackRock MuniVest Fund, Inc (MVF), abrdn World Healthcare Fund (THW), Palmer Square Capital BDC Inc. (PSBD), and First Trust Enhanced Equity Income Fund. (FFA). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate HQL's relative position within its industry.